Available datapackage for study 'A Phase 3, Randomized Study of Nivolumab Plus Ipilimumab in Combination With Chemotherapy vs Chemotherapy Alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer'

The purpose of this study is to determine whether Nivolumab, Ipilimumab combined with chemotherapy is more effective than chemotherapy by itself when treating stage IV NSCLC as the first treatment given for the disease

本研究旨在明确：纳武利尤单抗（Nivolumab）联合伊匹木单抗（Ipilimumab）与化疗联用，对比单纯化疗用于IV期非小细胞肺癌（non-small cell lung cancer, NSCLC）一线治疗的临床疗效优劣。